Cite
Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation
MLA
Park, Eui Kyun, et al. “Furosin, an Ellagitannin, Suppresses RANKL-Induced Osteoclast Differentiation and Function through Inhibition of MAP Kinase Activation and Actin Ring Formation.” Biochemical & Biophysical Research Communications, vol. 325, no. 4, Dec. 2004, pp. 1472–80. EBSCOhost, https://doi.org/10.1016/j.bbrc.2004.10.197.
APA
Park, E. K., Kim, M. S., Lee, S. H., Kim, K. H., Park, J.-Y., Kim, T.-H., Lee, I.-S., Woo, J.-T., Jung, J.-C., Shin, H.-I., Choi, J.-Y., & Kim, S.-Y. (2004). Furosin, an ellagitannin, suppresses RANKL-induced osteoclast differentiation and function through inhibition of MAP kinase activation and actin ring formation. Biochemical & Biophysical Research Communications, 325(4), 1472–1480. https://doi.org/10.1016/j.bbrc.2004.10.197
Chicago
Park, Eui Kyun, Myung Sunny Kim, Seung Ho Lee, Kyung Hee Kim, Ju-Young Park, Tae-Ho Kim, In-Seon Lee, et al. 2004. “Furosin, an Ellagitannin, Suppresses RANKL-Induced Osteoclast Differentiation and Function through Inhibition of MAP Kinase Activation and Actin Ring Formation.” Biochemical & Biophysical Research Communications 325 (4): 1472–80. doi:10.1016/j.bbrc.2004.10.197.